l carnitine cancer risk and Cardiovascular Disease: Shared Factors, Mechanisms, and Clinical Implications: JACC: CardioOncology State-of-the-Art Review The carnitine system and cancer
Description
Metabolism of polyamines and kidney disease: a promising therapeutic target
This inconsistency in definition further complicates the study of the metabolic characteristics of MCACs
Additionally, Tredici et al
They have been reported to reduce symptoms of angina and peripheral vascular disease, and they may improve outcomes for people with serious heart conditions, such as coronary heart disease or heart failure [5]
